Enxymatic Creatinine Test
Enzymatic Method, Creatinine. 510(k) K812095, from Boehringer Mannheim Corp. (Walker, MI). Product code JFY, class 2.
As of Nov 22, 2026, K812095 is an FDA 510(k) held by Boehringer Mannheim Corp., substantially equivalent on Aug 31, 1981 after 38 days, with no recalls tied to it in FDA's recall database.
- Review time: 38 days
- Recalls: 0
- Cited as a predicate by: 2 devices
- CreaK981799 · Abbott Laboratories · Jul 22, 1998
- Creatinine (Crea)K981240 · Abbott Laboratories · May 29, 1998
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Type
- Traditional
- Received
- Jul 24, 1981
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files